Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

An Hendrix

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2022
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, et al.
Journal of Extracellular Vesicles|January 29, 2026
Updating MISEV: When, What, How, and Why?Naveed Akbar, Dylan Burger, Benedetta Bussolati, et al.
Gynecologic Oncology|November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trialEmiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Journal of Extracellular Vesicles|February 10, 2023
A compendium of single extracellular vesicle flow cytometryJoshua A Welsh, Ger J A Arkesteijn, Michel Bremer, et al.
Cancer Research|September 28, 2014
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic propertiesMarie Stampe Ostenfeld, Dennis K Jeppesen, Jens R Laurberg, et al.
Circulation Research|May 13, 2017
Methodological Guidelines to Study Extracellular VesiclesFrank A W Coumans, Alain R Brisson, Edit I Buzas, et al.
Journal of Extracellular Vesicles|March 5, 2020
MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experimentsJoshua A Welsh, Edwin Van Der Pol, Ger J A Arkesteijn, et al.
Nature Communications|July 25, 2019
The generation and use of recombinant extracellular vesicles as biological reference materialEdward Geeurickx, Joeri Tulkens, Bert Dhondt, et al.
ACS Nano|March 16, 2016
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in NanomedicineStefano Fais, Lorraine O'Driscoll, Francesc E Borras, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nufel, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2022
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO studyEmiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, et al.
Journal of Extracellular Vesicles|January 29, 2026
Updating MISEV: When, What, How, and Why?Naveed Akbar, Dylan Burger, Benedetta Bussolati, et al.
Gynecologic Oncology|November 8, 2024
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trialEmiel A De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, et al.
Journal of Extracellular Vesicles|February 10, 2023
A compendium of single extracellular vesicle flow cytometryJoshua A Welsh, Ger J A Arkesteijn, Michel Bremer, et al.
Cancer Research|September 28, 2014
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic propertiesMarie Stampe Ostenfeld, Dennis K Jeppesen, Jens R Laurberg, et al.
Circulation Research|May 13, 2017
Methodological Guidelines to Study Extracellular VesiclesFrank A W Coumans, Alain R Brisson, Edit I Buzas, et al.
Journal of Extracellular Vesicles|March 5, 2020
MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experimentsJoshua A Welsh, Edwin Van Der Pol, Ger J A Arkesteijn, et al.
Nature Communications|July 25, 2019
The generation and use of recombinant extracellular vesicles as biological reference materialEdward Geeurickx, Joeri Tulkens, Bert Dhondt, et al.
ACS Nano|March 16, 2016
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in NanomedicineStefano Fais, Lorraine O'Driscoll, Francesc E Borras, et al.
Pageof 12